Who is sponsoring NCT04049188?

NCT04049188 is sponsored by Care Partners.

What drugs are being tested in NCT04049188?

Interventions in NCT04049188: Single-Fraction Palliative Radiation Therapy.

What condition does NCT04049188 study?

NCT04049188 studies Cancer Metastatic.

Is NCT04049188 still recruiting?

NCT04049188 is currently status unknown. Last updated 23 January 2020.

Last reviewed 2020-01-23 · How we verify

NCT04049188: SFPRT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Access to Single-Fraction Palliative Radiation Therapy in Cancer Patients Enrolled in Hospice

Status unknown NA Last updated 23 January 2020

What this trial tests

NA trial testing Single-Fraction Palliative Radiation Therapy in Cancer Metastatic in 31 participants. Status unknown.

Timeline

1 January 2020

Primary endpoint
1 January 2021

31 December 2021

Quick facts

Lead sponsor	Care Partners
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	31
Start date	1 January 2020
Primary completion	1 January 2021
Estimated completion	31 December 2021
Sites	1 location across United States

Drugs / interventions tested

Single-Fraction Palliative Radiation Therapy

Conditions studied

Cancer Metastatic — all drugs for Cancer Metastatic →

Sponsor

Care Partners

Who can join

Adults 18 to 100, any sex, with Cancer Metastatic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Feasibility study to report on the impact of ACCESS of single-fraction radiation therapy on cancer patients with bone metastases enrolled in hospice care.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cancer Metastatic

Currently open trials in the same condition.

NCT06391242 — Stereotactic Body Radiotherapy vs Conventional Palliative Radiotherapy for Painful Non-Spine Bone Metastases · Phase 3 · recruiting
NCT05785494 — Web-based Support for Family Caregivers of Patients With Advanced Cancer · NA · active not recruiting
NCT05103358 — Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 G · Phase 2 · active not recruiting
NCT05096923 — UNC Childhood, Adolescent, and Young Adult Cancer Cohort · recruiting
NCT04817956 — Improving Public Cancer Care by Implementing Precision Medicine in Norway · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04049188 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Care Partners
Last refreshed: 23 January 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04049188.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing